Olprinone

Olprinone (INN) is a cardiotonic agent.[1] It has been marketed in Japan since 1996.[2]

Olprinone
Clinical data
Routes of
administration		IV
Legal status
Legal status
  • Rx-only (JP). Not marketed in US and the EU
Identifiers
IUPAC name
  • 5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-1H-pyridine-3-carbonitrile
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H10N4O
Molar mass250.261 g·mol−1
3D model (JSmol)
SMILES
  • Cc1[nH]c(=O)c(C#N)cc1-c1ccc2nccn2c1
InChI
  • InChI=1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19) N
  • Key:JPAWFIIYTJQOKW-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

References
  1. Uemura Y, Tanaka S, Ida S, Yuzuriha T (December 1993). "Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs". J. Pharm. Pharmacol. 45 (12): 1077–81. doi:10.1111/j.2042-7158.1993.tb07184.x. PMID 7908977.
  2. (in English)"Coretec Injection 5 mg" (PDF). Eisai Co. April 2005. Retrieved 2008-06-26.
  • Media related to Olprinone at Wikimedia Commons


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.